Demographic Characteristics, Laboratory Findings, Radiological Features, and Outcomes of Patients with COVID-19: A Single-center Descriptive Study
DOI:
https://doi.org/10.3889/oamjms.2023.11554Keywords:
COVID-19, Coronavirus, Demography, Epidemiology, OutcomesAbstract
The coronavirus disease 2019 (COVID-19) has resulted in a global crisis, affecting hundreds of millions of individuals, with Indonesia reporting a significant increase in cases in July 2021. Therefore, this study aims to describe the clinical, laboratory findings, radiological features, and outcomes of hospitalized patients with COVID-19. This retrospective study was carried out using 606 hospitalized COVID-19 patients who were admitted to the isolation ward in a Hospital in South Jakarta, Indonesia, from January 1 to April 30, 2021. The median age of the patients was 45 years, 55.6% were male, and 85.5% had non-severe diseases, with the most common presenting symptoms being fever, cough, and gastrointestinal symptoms. Patients with severe disease were significantly older (P<0.001), more likely to have hypertension (P<0.05) and diabetes (P<0.001), have an increased CRP (P<0.001), high ferritin (P<0.001), and increased d-dimer (P<0.001). Compared to patients who survived, patients who had died were older (P<0.001), had hypertension (P=0.013), increased CRP (P<0.001), high ferritin (P=0.002), and increased d-dimer (P=0.006). These results showed that older age, comorbidities, and a higher level of CRP, ferritin, and d-dimer increased the risk of severe disease and poor clinical outcomes in hospitalized COVID-19 patients.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
World Health Organization. WHO Director-general’s Opening Remarks at the Media Briefing on COVID-19. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020 [Last accessed on 2022 June 20].
World Health Organization. Weekly Epidemiological Update on COVID-19-29 June 2021. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-29-june-2021 [Last accessed on 2022 June 20].
World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report-63. Available from: https://www.cdn.who.int/media/docs/default-source/searo/indonesia/covid19/external-situation-report-63_14-july-2021.pdf?sfvrsn=a84bb425_5 [Last accessed on 2022 June 22].
Zhan Y, Yin H, Yin JY. B.1.617.2 (Delta) variant of SARS-CoV-2: Features, transmission and potential strategies. Int J Biol Sci. 2022;18(5):1844-51. https://doi.org/10.7150/ijbs.66881 PMid:35342345 DOI: https://doi.org/10.7150/ijbs.66881
Dyer O. COVID-19: Indonesia becomes Asia’s new pandemic epicentre as delta variant spreads. BMJ. 2021;374:n1815. https://doi.org/10.1136/bmj.n1815 PMid:34272255 DOI: https://doi.org/10.1136/bmj.n1815
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. https://doi.org/10.1001/jama.2020.1585 PMid:32031570 DOI: https://doi.org/10.1001/jama.2020.1585
Wang Y, Luo S, Zhou CS, Wen ZQ, Chen W, Chen W, et al. Clinical and radiological characteristics of COVID-19: A multicentre, retrospective, observational study. Hong Kong Med J. 2021;27(1):7-17. https://doi.org/10.12809/hkmj208725 PMid:32848097 DOI: https://doi.org/10.12809/hkmj208725
Susanto AD, Rozaliyani A, Prasetyo B, Agustin H, Baskoro H, Arifin AR, et al. Epidemiological and clinical features of COVID-19 patients at National Emergency Hospital Wisma Atlet Kemayoran, Jakarta, Indonesia. Natl Public Health J. 2021;16(1):11-6. https://doi.org/10.21109/kesmas.v0i0.5233 DOI: https://doi.org/10.21109/kesmas.v0i0.5233
Chamorro EM, Tascón AD, Sanz LI, Vélez SO, Nacenta SB. Radiologic diagnosis of patients with COVID-19. Radiología (Engl Ed). 2021;63(1):56-73. https://doi.org/10.1016/j.rx.2020.11.001 PMid:33339622 DOI: https://doi.org/10.1016/j.rxeng.2020.11.001
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ. 2020;369:m1985. https://doi.org/10.1136/bmj.m1985 PMid:32444460 DOI: https://doi.org/10.1136/bmj.m1985
Rahman A, Sathi NJ. Risk factors of the severity of COVID-19: A meta-analysis. Int J Clin Pract. 2021;75(7):e13916. https://doi. org/10.1111/ijcp.13916 PMid:33372407 DOI: https://doi.org/10.1111/ijcp.13916
Mikami T, Miyashita H, Yamada T, Harrington M, Steinberg D, Dunn A, et al. Risk factors for mortality in patients with COVID-19 in New York city. J Gen Intern Med. 2021;36(1):17-26. https://doi.org/10.1007/s11606-020-05983-z PMid:32607928 DOI: https://doi.org/10.1007/s11606-020-05983-z
Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. https://doi.org/10.1016/j.jcv.2020.104364 PMid:32311650 DOI: https://doi.org/10.1016/j.jcv.2020.104364
Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020;21(2):1-11. https://doi.org/10.1177/1470320320926899 PMid:32408793 DOI: https://doi.org/10.1177/1470320320926899
AbuRuz S, Al-Azayzih A, ZainAlAbidin S, Beiram R, Al Hajjar M. Clinical characteristics and risk factors for mortality among COVID-19 hospitalized patients in UAE: Does ethnic origin have an impact. PLoS One. 2022;17(3):e0264547. https://doi.org/10.1371/journal.pone.0264547 PMid:35235580 DOI: https://doi.org/10.1371/journal.pone.0264547
Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, et al. COVID-19 patients with hypertension have more severe disease: A multicenter retrospective observational study. Hypertens Res. 2020;43(8):824-31. https://doi.org/10.1038/s41440-020-0485-2 PMid:32483311 DOI: https://doi.org/10.1038/s41440-020-0485-2
Li G, Chen Z, Lv Z, Li H, Chang D, Lu J. Diabetes mellitus and COVID-19: Associations and possible mechanisms. Int J Endocrinol. 2021;2021:7394378. https://doi.org/10.1155/2021/7394378 DOI: https://doi.org/10.1155/2021/7394378
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):e3319. https://doi.org/10.1002/dmrr.3319 PMid:32233013 DOI: https://doi.org/10.1002/dmrr.3319
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43. https://doi.org/10.1001/jamainternmed.2020.0994 PMid:32167524 DOI: https://doi.org/10.1001/jamainternmed.2020.0994
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. https://doi.org/10.3389/fimmu.2018.00754 PMid:29706967 DOI: https://doi.org/10.3389/fimmu.2018.00754
Yitbarek GY, Walle AG, Asnakew S, Ayele FY, Gare MB, Mulu AT, et al. The role of C-reactive protein in predicting the severity of COVID-19 disease: A systematic review. SAGE Open Med. 2021;9:1-8. https://doi.org/10.1177/20503121211050755 PMid:34659766 DOI: https://doi.org/10.1177/20503121211050755
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, c-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370. https://doi.org/10.1016/j.jcv.2020.104370 PMid:32344321 DOI: https://doi.org/10.1016/j.jcv.2020.104370
Kaushal K, Kaur H, Sarma P, Bhattacharyya A, Sharma DJ, Prajapat M, et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care. 2022;67:172-81. https://doi.org/10.1016/j.jcrc.2021.09.023 PMid:34808527 DOI: https://doi.org/10.1016/j.jcrc.2021.09.023
Alroomi M, Rajan R, Omar AA, Alsaber A, Pan J, Fatemi M, et al. Ferritin level: A predictor of severity and mortality in hospitalized COVID-19 patients. Immun Inflamm Dis. 2021;9(4):1648-55. https://doi.org/10.1002/iid3.517 PMid:34438471 DOI: https://doi.org/10.1002/iid3.517
Vargas-Vargas M, Cortés-Rojo C. Ferritin levels and COVID-19. Rev Panam Salud Publica. 2020;44:e72. https://doi.org/10.26633/RPSP.2020.72 PMid:32547616 DOI: https://doi.org/10.26633/RPSP.2020.72
Varikasuvu SR, Varshney S, Dutt N, Munikumar M, Asfahan S, Kulkarni PP, et al. D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: A systematic review and meta-analysis of 100 studies. Sci Rep. 2021;11(1):21888. https://doi.org/10.1038/s41598-021-01462-5 PMid:34750495 DOI: https://doi.org/10.1038/s41598-021-01462-5
Soni M, Gopalakrishnan R, Vaishya R, Prabu P. D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes Metab Syndr. 2020;14(6):2245-9. https://doi.org/10.1016/j.dsx.2020.11.007 PMid:33395786 DOI: https://doi.org/10.1016/j.dsx.2020.11.007
Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Health West Pac. 2021;9:100108. https://doi.org/10.1016/j.lanwpc.2021.100108 PMid:33681830 DOI: https://doi.org/10.1016/j.lanwpc.2021.100108
Downloads
Published
How to Cite
License
Copyright (c) 2023 Wulyo Rajabto, Prasna Pramita, Hilman Tadjoedin, Donnie Lumban Gaol, R.A. Sri Hardini, Nirmala Purbasari Tarigan, Vitya Chandika, Rumuat Semuel Wullul Manangka, Maria Pyrhadistya (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0